Pharmaceutical Executive, October 1st, 2006
The problem isn't that there's conflict between safety and efficacy or between getting a useful medicine to market and protecting the public from a dangerous one. The problem is that the conflict isn't well structured. That needs to change.
AS I LOOK THROUGH THIS ISSUE of Pharm Exec, I realize that there is an unintended theme running through it: Over and over our authors look at the kinds of structured conflicts that keep the industry functioning (and that threaten it when they get out of balance.
Our profile of the generic giant Teva (on page 48) is a good example. Here is a company that t...
HighBeam Research, Free Preview: 'In Conflict'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
